Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ceftriaxone 2g powder for solution for injection vials
0501021G0AAADAD
|
Ceftriaxone sodium | Ceftriaxone sodium | Infections | 76 |
|
Teicoplanin 400mg inj vials
0501070T0AAAAAA
|
Teicoplanin (Systemic) | Teicoplanin | Infections | 76 |
|
Diflucan 50mg/5ml oral suspension
0502010B0BBAGAG
|
Diflucan | Fluconazole | Infections | 73 |
|
Sporanox 100mg capsules
0502010C0BBAAAA
|
Sporanox | Itraconazole | Infections | 73 |
|
Amoxil 500mg capsules
0501013B0BCABAB
|
Amoxil (Systemic) | Amoxicillin | Infections | 72 |
|
Metronidazole 1g suppositories
0501110C0AAAHAH
|
Metronidazole (Systemic) | Metronidazole | Infections | 70 |
|
Sulfadiazine 500mg tablets
0501080J0AAABAB
|
Sulfadiazine | Sulfadiazine | Infections | 70 |
|
Zovirax 200mg/5ml oral suspension
0503021C0BBABAA
|
Zovirax (Systemic) | Aciclovir | Infections | 70 |
|
Ampicillin 500mg capsules
0501013E0AAABAB
|
Ampicillin | Ampicillin | Infections | 69 |
|
Cidomycin 80mg/2ml solution for injection ampoules
0501040H0BBAAAA
|
Cidomycin (Systemic) | Gentamicin sulfate | Infections | 68 |
|
Griseofulvin 175mg/5ml oral suspension
0502050B0AACVCV
|
Griseofulvin (Systemic) | Griseofulvin | Infections | 66 |
|
Minocin MR 100mg capsules
0501030P0BBACAC
|
Minocin | Minocycline hydrochloride | Infections | 66 |
|
Quinine sulfate 200mg/5ml oral suspension
0504010Y0AABDBD
|
Quinine sulfate | Quinine sulfate | Infections | 66 |
|
Nitrofurantoin 25mg/5ml oral liquid
0501130R0AAAMAM
|
Nitrofurantoin | Nitrofurantoin | Infections | 62 |
|
Cefuroxime 125mg/5ml oral suspension
0501021K0AAACAC
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 61 |
|
Fucidin 250mg tablets
0501070N0BBAAAD
|
Fucidin (Injection/Powder/Tablet) | Sodium fusidate | Infections | 61 |
|
Klaricid XL 500mg tablets
0501050B0BBAEAE
|
Klaricid | Clarithromycin | Infections | 59 |
|
Malarone 250mg/100mg tablets
0504010U0BBAAAA
|
Malarone | Proguanil hydrochloride with atovaquone | Infections | 58 |
|
Amoxicillin 500mg tablets
0501013B0AABDBD
|
Amoxicillin | Amoxicillin | Infections | 57 |
|
Nitrofurantoin 50mg/5ml oral suspension sugar free
0501130R0AACMCM
|
Nitrofurantoin | Nitrofurantoin | Infections | 57 |
|
Terbinafine 250mg/5ml oral solution
0502050C0AAAEAE
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | 57 |
|
Cefuroxime 125mg tablets
0501021K0AAAAAA
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 49 |
|
Inosine acedoben dimepranol 500mg tablets
0503021D0AAAAAA
|
Inosine pranobex | Inosine pranobex | Infections | 49 |
|
Teicoplanin 200mg inj vials
0501070T0AAABAB
|
Teicoplanin (Systemic) | Teicoplanin | Infections | 48 |
|
Clarithromycin 250mg granules for oral suspension sachets
0501050B0AAAFAF
|
Clarithromycin | Clarithromycin | Infections | 47 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.